INTEGRATIVE RESEARCH LABORATORY,INTEGRATIVE RESEARCH LABORATORY SWEDEN AB
申请号：
IN201717041191
公开号：
IN201717041191A
申请日:
2017.11.17
申请国别(地区):
IN
年份:
2018
代理人:
摘要：
The present disclosure relates to certain novel compounds of Formula (I) and to their utility in modulation of levels of monoamines dopamine norepinephrine and serotonin in cerebral cortical areas of the mammalian brain and more specifically for the treatment of central nervous system disorders.
